Pharmacist Follow-up, a Qualitative Study of Patient Experience

NCT ID: NCT01131715

Last Updated: 2020-06-29

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 4 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2010-02-28
• Study Completion Date: 2012-07-31

Brief Summary

A pharmacist follow-up procedure is under development. Patients with coronary heart disease (CHD) is being followed up by a pharmacist for one year with three meetings; at discharge from hospital, after three months and after one year. The evaluation is basically based on quantitative measures as achievement of therapeutic goals, number of drug related problems detected, hospitalisations etc. However, the patients' own experience with the follow-up procedure cannot be evaluated using these measures. Thus, a qualitative approach is needed. In this study, a total of four patients participating in the follow-up will be included and interviewed. A semistructured interview guide will be used. Interviews will be taped, transcribed and analyzed with the intention to explore how patients experience the follow-up from the pharmacist. A thoruough content analysis will be performed. Patients included must have met the pharmacist at least twice. The pharmacist in charge of the follow-up will recruit patients and hand out study information. Patients will reply to the principal investigator of the study and thus kept anonymous for the pharmacist in charge of the follow-up. No pressure will be put on the patients to join, but it will be emphasized that it will help evaluating the procedure.

Detailed Description

See full publication on http://www.biomedcentral.com/1756-0500/7/197 Garcia et al. BMC Research Notes 2014, 7:197

Conditions

Patient Satisfaction; Patient Preference

Study Design

• Observational Model Type: OTHER
• Study Time Perspective: OTHER

Study Groups

Study group

Patients who are included in the pharmacist follow-up procedure

No interventions assigned to this group

Eligibility Criteria

Inclusion Criteria

• must have met the pharmacist at least twice
• living within the area of Tromsoe city so that interviews are possible

Exclusion Criteria

• none as patients are already enrolled in another study

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 80 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University of Tromso

OTHER

Sponsor Role: collaborator

Hospital Pharmacy of North Norway Trust

OTHER

Sponsor Role: lead

Responsible Party

Beate Hennie Garcia, PhD

Associate Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Lars Smaabrekke, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Tromso

Beate H Garcia, PhD

Role: STUDY_CHAIR

Hospital Pharmacy of North Norway Trust

Locations

University of Tromsoe

Tromsø, , Norway

Countries

Norway

References

Garcia BH, Storli SL, Smabrekke L. A pharmacist-led follow-up program for patients with coronary heart disease in North Norway--a qualitative study exploring patient experiences. BMC Res Notes. 2014 Mar 29;7:197. doi: 10.1186/1756-0500-7-197.

Reference Type: DERIVED

PMID: 24679131 (View on PubMed)

Related Links

https://helseforskning.etikkom.no/?_ikbLanguageCode=us

Regional Committees for Medical and Health Research Ethics (REK)

http://www.biomedcentral.com/1756-0500/7/197

Published article

Other Identifiers

SHAN-002

Identifier Type: -

Identifier Source: org_study_id